Plasma Therapy Coronavirus

Convalescent plasma does not reduce the risk of intubation or death in COVID-19 patients, according to a study which found that people receiving the therapy experienced more serious adverse events than those getting standard care.

Convalescent plasma therapy, widely used in hospitals for treating moderate and serious coronavirus patients, has been dropped from the centre's list of recommended lines of treatment for COVID-19.

India's top medical research body -- Indian Council of Medical Research (ICMR) on Wednesday said that indiscriminate use of Convalescent Plasma Therapy (CPT) should be avoided as it does not reduce mortality in COVID-19 patients.

The Aam Aadmi Party-led Delhi government has opposed the possible removal of convalescent plasma therapy (CPT) from the national guideline on treatment of coronavirus. It has urged the central government to continue its use as a COVID-19 treatment for severely ill coronavirus patients.

Convalescent plasma therapy may be removed from the national guideline on treatment of coronavirus, chief of India's top medical research body ICMR Dr Balram Bhargava said at a Health Ministry briefing today.

Union Health Minister Dr Harsh Vardhan on Sunday cautioned against "routine use" of plasma therapy and anti-viral drug Remdesivir to treat COVID-19 patients, stating that these are "investigational therapies" and should be adopted "rationally".

Delhi Deputy Chief Minister Manish Sisodia, who was admitted to hospital on Wednesday after testing positive for COVID-19, underwent plasma therapy at a private hospital in the city today to help him fight the infectious virus

Health Minister Satyender Jain, who recovered from COVID-19 in June a week after he was given convalescent plasma therapy, CPT, said the Delhi government will continue using it as a line of treatment for severe symptoms a day after a study by the India Council of Medical Research (ICMR) stated that giving plasma had negligible effect on reducing de...

The India Council of Medical Research, in a study, said plasma therapy for COVID-19 neither reduces the death risk nor does it slow down the progression of the disease from mild to severe stage.

The Convalescent Plasma (CP) therapy didn't help in reducing death due to the coronavirus, the India Council of Medical Research (ICMR) revealed in a study.

What Delhi did yesterday, America does today, said Chief Minister Arvind Kejriwal on Monday as his government claimed that the US adopted the model of convalescent plasma therapy for treatment of critically-ill coronavirus patients, taking a cue from the "Delhi Model" of battling COVID-19.

The World Health Organization on Monday was cautious about endorsing the use of recovered COVID-19 patients' plasma to treat those who are ill, saying evidence it works remains "low quality" even as the United States issued emergency authorization for such therapies.

American authorities announced on Sunday an emergency approval of blood plasma from recovered coronavirus patients as a treatment against the disease that has killed over 176,000 in the US.

COVID-19 warrior Dr Abhijit Sarma is back on duty after battling the coronavirus that he contracted while on duty on July 19. The Guwahati Medical College Hospital superintendent was given convalescent plasma soon after he was infected and he believes it worked.

Convalescent plasma therapy did not show benefit in reducing mortality risk among COVID-19 patients, according to an interim analysis of a randomised controlled trial done at AIIMS in Delhi to assess the efficacy of this mode of treatment.

Convalescent plasma does not reduce the risk of intubation or death in COVID-19 patients, according to a study which found that people receiving the therapy experienced more serious adverse events than those getting standard care.

Convalescent plasma therapy, widely used in hospitals for treating moderate and serious coronavirus patients, has been dropped from the centre's list of recommended lines of treatment for COVID-19.

India's top medical research body -- Indian Council of Medical Research (ICMR) on Wednesday said that indiscriminate use of Convalescent Plasma Therapy (CPT) should be avoided as it does not reduce mortality in COVID-19 patients.

The Aam Aadmi Party-led Delhi government has opposed the possible removal of convalescent plasma therapy (CPT) from the national guideline on treatment of coronavirus. It has urged the central government to continue its use as a COVID-19 treatment for severely ill coronavirus patients.

Convalescent plasma therapy may be removed from the national guideline on treatment of coronavirus, chief of India's top medical research body ICMR Dr Balram Bhargava said at a Health Ministry briefing today.

Union Health Minister Dr Harsh Vardhan on Sunday cautioned against "routine use" of plasma therapy and anti-viral drug Remdesivir to treat COVID-19 patients, stating that these are "investigational therapies" and should be adopted "rationally".

Delhi Deputy Chief Minister Manish Sisodia, who was admitted to hospital on Wednesday after testing positive for COVID-19, underwent plasma therapy at a private hospital in the city today to help him fight the infectious virus

Health Minister Satyender Jain, who recovered from COVID-19 in June a week after he was given convalescent plasma therapy, CPT, said the Delhi government will continue using it as a line of treatment for severe symptoms a day after a study by the India Council of Medical Research (ICMR) stated that giving plasma had negligible effect on reducing de...

The India Council of Medical Research, in a study, said plasma therapy for COVID-19 neither reduces the death risk nor does it slow down the progression of the disease from mild to severe stage.

The Convalescent Plasma (CP) therapy didn't help in reducing death due to the coronavirus, the India Council of Medical Research (ICMR) revealed in a study.

What Delhi did yesterday, America does today, said Chief Minister Arvind Kejriwal on Monday as his government claimed that the US adopted the model of convalescent plasma therapy for treatment of critically-ill coronavirus patients, taking a cue from the "Delhi Model" of battling COVID-19.

The World Health Organization on Monday was cautious about endorsing the use of recovered COVID-19 patients' plasma to treat those who are ill, saying evidence it works remains "low quality" even as the United States issued emergency authorization for such therapies.

American authorities announced on Sunday an emergency approval of blood plasma from recovered coronavirus patients as a treatment against the disease that has killed over 176,000 in the US.

COVID-19 warrior Dr Abhijit Sarma is back on duty after battling the coronavirus that he contracted while on duty on July 19. The Guwahati Medical College Hospital superintendent was given convalescent plasma soon after he was infected and he believes it worked.

Convalescent plasma therapy did not show benefit in reducing mortality risk among COVID-19 patients, according to an interim analysis of a randomised controlled trial done at AIIMS in Delhi to assess the efficacy of this mode of treatment.